Cerebroprotein Hydrolysate- New Paradigm in Management of Neurological Problems

Oommen, Arun

doi:10.15406/jnsk.2015.02.00076

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most commonly headache, nausea, vertigo, increased sweating, agitation, fever, flu-like syndrome, hallucination, confusion, etc have been reported. It is contraindicated in hypersensitivity, epilepsy and severe renal impairment and used with caution in pregnancy and lactation [6].…”

Section: Introductionmentioning

confidence: 99%

Cerebroprotein Hydrolysate Induced Systemic Inflammatory Response Syndrome (Sirs): A Case Report

Devi

Sarma²,

Choudhury

2016

Int J Pharm Pharm Sci

View full text Add to dashboard Cite

Cerebroprotein hydrolysate is a newer pharmacological neurotropic agent and considered as a promising therapeutic agent for dementia, Alzheimer's disease, traumatic brain injury and acute ischaemic stroke. Studies revealed that most of the side effects are minor. Here, we reported a case of Systemic inflammatory response syndrome (SIRS) probably due to use of Cerebroprotein hydrolysate in a patient with acute ischaemic stroke.

show abstract

Section: Introductionmentioning

confidence: 99%